“The bioeconomy can and should be the path for the re-industrialization of Brazil, fostering much needed innovations and development of products and processes that will fast-track the establishment of the this new norm in a global scale”. To say this – in this exclusive interview with Il Bioeconomista – is Bernardo Silva, Executive President at Brazilian Industrial Biotechnology Association (in Portuguese ABBI – Associação Brasileira de Biotecnologia Industrial), a trade association that brings together companies and institutions developing and using microorganisms and its derivatives to deliver renewable products for industries and consumers worldwide. The founding members of ABBI are Amyris, BASF, BioChemtex, BP, Centro de Tecnologia Canavieira, Dow, DSM, DuPont, GranBio, Novozymes, Raízen and Rhodia. With Silva we talk about Brazilian bioeconomy and the country’s national strategy to support the field. “The ambition to establish a vibrant bioeconomy in Brazil, which values our comparative advantages and is able to realize the opportunities arising from this new model of development, entails a joint effort between government, business and civil society to discuss, define and practice a plan that ensures the alignment of policies in place and long-term strategies, paving the way for Brazil fulfill its role as a leader a global bio-based economy.”
Interview by Mario Bonaccorso








